G339-0830 Screening compound: 1-[(3-methoxyphenyl)methyl]-N-({1-[(4-methylphenyl)methyl]piperidin-4-yl}methyl)-1H-indazole-6-carboxamide

G339-0830 Screening compound: 1-[(3-methoxyphenyl)methyl]-N-({1-[(4-methylphenyl)methyl]piperidin-4-yl}methyl)-1H-indazole-6-carboxamide
G339-0830 Screening compound: 1-[(3-methoxyphenyl)methyl]-N-({1-[(4-methylphenyl)methyl]piperidin-4-yl}methyl)-1H-indazole-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G339-0830
1-[(3-methoxyphenyl)methyl]-N-({1-[(4-methylphenyl)methyl]piperidin-4-yl}methyl)-1H-indazole-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G339-0830

Molecular Formula

C30H34N4O2 (C30 H34 N4 O2)

Compound Name

1-[(3-methoxyphenyl)methyl]-N-({1-[(4-methylphenyl)methyl]piperidin-4-yl}methyl)-1H-indazole-6-carboxamide

IUPAC name

1-[(3-methoxyphenyl)methyl]-N-({1-[(4-methylphenyl)methyl]piperidin-4-yl}methyl)-1H-indazole-6-carboxamide

SMILES

Cc1ccc(CN2CCC(CNC(c3cc(n(Cc4cc(OC)ccc4)nc4)c4cc3)=O)CC2)cc1

InChI

InChI=1S/C30H34N4O2/c1-22-6-8-24(9-7-22)20-33-14-12-23(13-15-33)18-31-30(35)26-10-11-27-19-32-34(29(27)17-26)21-25-4-3-5-28(16-25)36-2/h3-11,16-17,19,23H,12-15,18,20-21H2,1-2H3,(H,31,35)

InChI Key

SOJSYILNOLPNGJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27136011

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.63

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.945

Distribution Coefficient, logD

2.224

Water Solubility, LogSw

-4.73

Polar Surface Area

49.360

Acid Dissociation Constant (pKa)

14.23

Base Dissociation Constant (pKb)

10.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

G339-0830 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G339-0830 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G339-0830?
Check Price and Availability of G339-0830, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G339-0830 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G339-0830
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G339-0830
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G339-0830 available by request